Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study - Top-Institutions - MDSpire

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study

  • By

  • Joseph Magagnoli

  • Tammy H. Cummings

  • Meenakshi Ambati

  • S. Scott Sutton

  • Jayakrishna Ambati

  • December 26, 2025

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Clinical Pharmacology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Epidemiology

  • #3

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Pharmacoepidemiology

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Clinical Epidemiology

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Rheumatology
    • Pharmacoepidemiology

Original Source(s)

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study

  • by Joseph Magagnoli, Tammy H. Cummings, Meenakshi Ambati, S. Scott Sutton, Jayakrishna Ambati

  • December 26, 2025

Related Content

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Evaluating the Quality and Content of Videos on Gout Available on Online Platforms: A Cross-Sectional Analysis

Serum Urate Goals Tied to Lower CV Risk

Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients